Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Nobuo Ida"'
Autor:
Reiji Nishio, Akihito Yasuda, Noriyasu Kamei, Mariko Takeda-Morishita, Nobuo Ida, Shuichi Yamamoto, Yoshiaki Terasawa, Kozo Takayama, Shingo Kikuchi
Publikováno v:
Journal of Pharmaceutical Sciences. 102:469-479
Our recent work has shown that the intestinal absorption of insulin can be improved significantly by coadministration of cell-penetrating peptides (CPPs), especially penetratin. However, a relatively high dose of penetratin is required to adequately
Publikováno v:
Journal of Controlled Release. 143:302-310
Penetratin, a 16-residue peptide, is used widely as a highly efficient delivery carrier for a wide range of poorly permeable therapeutic cargoes. The crucial structural features of penetratin remain unclear, as demonstrated by the difficulties encoun
Publikováno v:
International Journal of Infectious Diseases. 7(1):21-28
Objective: A new superantigen-adsorbing device (SAAD) was developed, and its characteristics and efficacy in septic animals were evaluated. Methods: The SAAD was prepared by stepwise chemical modification of a polystyrene-based composite fiber reinfo
Publikováno v:
Journal of Neurochemistry. 72:1457-1465
Amyloidogenic processing of the beta-amyloid precursor protein (APP) has been implicated in the pathology of Alzheimer's disease. Because it has been suggested that catabolic processing of the APP holoprotein occurs in acidic intracellular compartmen
Autor:
Sascha Weggen, Christian Haass, Konrad Beyreuther, Jürgen Grünberg, Nobuo Ida, Anke Diehlmann, Colin L. Masters, Thomas A. Bayer
Publikováno v:
Journal of Neuroscience Research. 56:405-419
Because distinct mutations in presenilin 1 and presenilin 2 are a major cause of early-onset familial Alzheimer's disease, we generated four monoclonal antibodies for the identification, localization, and investigation of presenilins in various cell
Autor:
Mari Blomberg, Nobuo Ida, Benita Engvall, Johannes Schröder, Malene Jensen, Tobias Hartmann, Konrad Beyreuther, Egon Werle, Lars Lannfelt, Johannes Pantel, M. Jauss, Lars-Olof Wahlund, Hans Basun
Publikováno v:
Annals of Neurology. 45:504-511
All mutations known to cause familial Alzheimer's disease (AD) act by increasing the levels of soluble beta-amyloid peptide (A beta), especially the longer form, A beta42. However, in vivo elevation of soluble A beta in sporadic AD has so far not bee
Autor:
Nobuo Ida, Stefan Wiemann, K. G. Anthony, S. Rondot, Konrad Beyreuther, Frank Breitling, Laura S. Frost, Melvyn Little, Stefan Dübel
Publikováno v:
Journal of Molecular Biology. 279:589-603
In order to develop a system which allows infection by an epitope-specific phage-antibody via an F-pilus expressing that epitope, a study on the expression of foreign sequences on F-pilin was undertaken. Initially, a plasmid library was constructed w
Autor:
David L. Charest, Peter B. Reiner, Nobuo Ida, Fred C. Lam, Julia Mills, Steven L. Pelech, Konrad Beyreuther
Publikováno v:
The Journal of Neuroscience. 17:9415-9422
Catabolic processing of the amyloid precursor protein (APP) is subject to regulatory control by protein kinases. We hypothesized that this regulation involves sequential activation of the enzymes mitogen-activated protein kinase kinase (MEK) and extr
Autor:
Gareth W. Roberts, Tobias Hartmann, Nobuo Ida, Konrad Beyreuther, David Allsop, Sophie Bieger, Colin L. Masters, Pentti J. Tienari, Carlos G. Dotti, Babara Brühl, Klaus Unsicker
Publikováno v:
Nature Medicine. 3:1016-1020
The Alzheimer amyloid precursor protein (APP) is cleaved by several proteases, the most studied, but still unidentified ones, are those involved in the release of a fragment of APP, the amyloidogenic beta-protein A beta. Proteolysis by gamma-secretas
Autor:
Konrad Beyreuther, Elina Ikonen, Mikael Simons, Andreas Weidemann, Nobuo Ida, Gerd Multhaup, Colin L. Masters, Carlos G. Dotti, Pentti J. Tienari
Publikováno v:
Proceedings of the National Academy of Sciences. 94:4125-4130
Cerebral plaques containing β-amyloid (βA4) represent an invariant pathological feature of Alzheimer disease (AD). βA4 is proteolytically generated from its parent molecule, amyloid precursor protein (APP). In nonneuronal cells βA4 has been shown